0001209191-18-020020.txt : 20180315
0001209191-18-020020.hdr.sgml : 20180315
20180315200242
ACCESSION NUMBER: 0001209191-18-020020
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180313
FILED AS OF DATE: 20180315
DATE AS OF CHANGE: 20180315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Varian John
CENTRAL INDEX KEY: 0001416176
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33958
FILM NUMBER: 18693929
MAIL ADDRESS:
STREET 1: ARYX THERAPEUTICS,INC.
STREET 2: 6300 DUMBARTON CIRCLE
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SELLAS Life Sciences Group, Inc.
CENTRAL INDEX KEY: 0001390478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 315 MADISON AVENUE
STREET 2: 4TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: (813) 864-4523
MAIL ADDRESS:
STREET 1: 315 MADISON AVENUE
STREET 2: 4TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
FORMER COMPANY:
FORMER CONFORMED NAME: Galena Biopharma, Inc.
DATE OF NAME CHANGE: 20110926
FORMER COMPANY:
FORMER CONFORMED NAME: RXi Pharmaceuticals Corp
DATE OF NAME CHANGE: 20110926
FORMER COMPANY:
FORMER CONFORMED NAME: GALENA BIOPHARMA, INC.
DATE OF NAME CHANGE: 20110922
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-13
0
0001390478
SELLAS Life Sciences Group, Inc.
SLS
0001416176
Varian John
C/O SELLAS LIFE SCIENCES GROUP, INC.
315 MADISON AVENUE, 4TH FLOOR
NEW YORK
NY
10017
1
0
0
0
Stock Option (Right to Buy)
5.24
2018-03-13
4
A
0
11000
0.00
A
2028-03-12
Common Stock
11000
11000
D
The option shares will vest and became exercisable in equal monthly installments for thirty-six (36) months following the March 13, 2018 grant date, provided that the Reporting Person remains in service with the Issuer through each such monthly vesting date.
John Varian, by /s/ Ron A. Metzger, Attorney-in-Fact
2018-03-15